10 November 2021 - Twenty months into the pandemic, the FDA remains consumed with vital decisions on coronavirus vaccines and treatments. 

But it’s also facing key questions on the future of medical software that can help make clinical decisions, deliver virtual care and chart a course for the post-pandemic world.

Read Politico article